De Rucci Healthy Sleep Co., Ltd. (SHE:001323)
China · Delayed Price · Currency is CNY 17.76
+0.06 (0.34%)
Sep 22, 2026, 3:04 PM CST
De Rucci Healthy Sleep Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 7,659 | 11,233 | 14,886 | 12,200 | 13,248 | - | |
Market Cap Growth | -36.94% | -24.54% | 22.01% | -7.91% | - | - |
Enterprise Value | 6,219 | 9,158 | 12,419 | 8,643 | 11,337 | - |
Last Close Price | 17.70 | 24.79 | 31.25 | 23.81 | 25.07 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 21.05 | 20.98 | 19.40 | 15.21 | 18.70 | - |
Forward PE | 15.48 | 14.19 | 17.35 | 13.98 | 16.28 | - |
PS Ratio | 1.46 | 2.15 | 2.66 | 2.19 | 2.28 | - |
PB Ratio | 1.80 | 2.53 | 3.30 | 2.63 | 3.04 | - |
P/TBV Ratio | 1.95 | 2.73 | 3.53 | 2.82 | 3.30 | - |
P/FCF Ratio | 38.75 | 69.33 | 20.97 | 7.93 | 515.42 | - |
P/OCF Ratio | 18.11 | 29.17 | 13.65 | 6.31 | 20.46 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 1.19 | 1.75 | 2.22 | 1.55 | 1.95 | - |
EV/EBITDA Ratio | 10.69 | 13.23 | 11.69 | 8.08 | 12.69 | - |
EV/EBIT Ratio | 19.17 | 19.48 | 14.78 | 9.87 | 15.78 | - |
EV/FCF Ratio | 31.46 | 56.53 | 17.50 | 5.62 | 441.06 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.32 | 0.30 | 0.24 | 0.11 | 0.02 | 0.09 |
Debt / EBITDA Ratio | 2.32 | 1.84 | 1.02 | 0.46 | 0.10 | 0.24 |
Debt / FCF Ratio | 6.84 | 8.18 | 1.55 | 0.33 | 3.96 | 1.06 |
Net Debt / Equity Ratio | -0.34 | -0.46 | -0.66 | -0.68 | -0.54 | -0.46 |
Net Debt / EBITDA Ratio | -2.66 | -2.97 | -2.80 | -2.96 | -2.65 | -1.28 |
Net Debt / FCF Ratio | -7.34 | -12.67 | -4.20 | -2.06 | -92.20 | -5.23 |
Asset Turnover | 0.71 | 0.68 | 0.76 | 0.86 | 1.13 | 1.63 |
Inventory Turnover | 9.84 | 10.31 | 12.43 | 11.99 | 12.00 | 12.65 |
Quick Ratio | 1.13 | 1.21 | 1.37 | 1.57 | 2.06 | 0.87 |
Current Ratio | 1.33 | 1.39 | 1.52 | 1.85 | 2.40 | 1.17 |
Return on Equity (ROE) | 8.09% | 11.79% | 16.76% | 17.83% | 20.46% | 30.88% |
Return on Assets (ROA) | 2.75% | 3.84% | 7.08% | 8.43% | 8.69% | 12.50% |
Return on Invested Capital (ROIC) | 10.45% | 20.47% | 46.60% | 42.26% | 36.84% | 67.31% |
Return on Capital Employed (ROCE) | 7.10% | 9.90% | 18.10% | 18.30% | 15.90% | 28.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 4.74% | 4.77% | 5.16% | 6.58% | 5.35% | - |
FCF Yield | 2.58% | 1.44% | 4.77% | 12.62% | 0.19% | - |
Dividend Yield | 8.16% | 5.85% | 5.09% | 3.82% | 7.25% | - |
Payout Ratio | 172.45% | 111.75% | 91.11% | 50.45% | 56.47% | - |
Buyback Yield / Dilution | 0.19% | 0.38% | 1.26% | -4.80% | -5.98% | -12.57% |
Total Shareholder Return | 8.39% | 6.23% | 6.35% | -0.98% | 1.28% | -12.57% |